Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 21% ± 5% | |
GABAergic neuron | 3 studies | 34% ± 6% | |
glutamatergic neuron | 3 studies | 40% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 644.72 | 1411 / 1445 | 99% | 7.18 | 181 / 183 |
breast | 99% | 234.21 | 454 / 459 | 95% | 4.86 | 1064 / 1118 |
intestine | 98% | 205.44 | 943 / 966 | 96% | 2.95 | 506 / 527 |
lung | 98% | 241.72 | 567 / 578 | 95% | 3.71 | 1098 / 1155 |
stomach | 96% | 198.25 | 344 / 359 | 97% | 3.09 | 278 / 286 |
skin | 100% | 1183.64 | 1806 / 1809 | 91% | 2.76 | 431 / 472 |
uterus | 100% | 267.78 | 170 / 170 | 88% | 5.00 | 405 / 459 |
prostate | 98% | 211.61 | 239 / 245 | 88% | 2.70 | 443 / 502 |
brain | 88% | 254.06 | 2335 / 2642 | 96% | 3.02 | 680 / 705 |
bladder | 95% | 194.10 | 20 / 21 | 85% | 3.01 | 430 / 504 |
adrenal gland | 100% | 310.39 | 258 / 258 | 78% | 2.31 | 180 / 230 |
thymus | 98% | 216.14 | 643 / 653 | 79% | 1.78 | 477 / 605 |
ovary | 96% | 186.76 | 173 / 180 | 80% | 2.11 | 345 / 430 |
kidney | 91% | 179.84 | 81 / 89 | 79% | 1.72 | 710 / 901 |
pancreas | 65% | 91.80 | 214 / 328 | 88% | 2.02 | 157 / 178 |
spleen | 100% | 237.46 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 235.10 | 1189 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 235.81 | 784 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 7.58 | 43 / 45 |
blood vessel | 94% | 172.32 | 1257 / 1335 | 0% | 0 | 0 / 0 |
heart | 88% | 252.02 | 761 / 861 | 0% | 0 | 0 / 0 |
liver | 53% | 85.92 | 120 / 226 | 32% | 0.53 | 130 / 406 |
eye | 0% | 0 | 0 / 0 | 69% | 1.39 | 55 / 80 |
lymph node | 0% | 0 | 0 / 0 | 62% | 2.23 | 18 / 29 |
peripheral blood | 51% | 165.57 | 478 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032958 | Biological process | inositol phosphate biosynthetic process |
GO_1901838 | Biological process | positive regulation of transcription of nucleolar large rRNA by RNA polymerase I |
GO_0043647 | Biological process | inositol phosphate metabolic process |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0035299 | Molecular function | inositol pentakisphosphate 2-kinase activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | IPPK |
Protein name | Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (IPK1 homolog) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase) Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) |
Synonyms | C9orf12 |
Description | FUNCTION: Phosphorylates Ins(1,3,4,5,6)P5 at position 2 to form Ins(1,2,3,4,5,6)P6 (InsP6 or phytate). InsP6 is involved in many processes such as mRNA export, non-homologous end-joining, endocytosis, ion channel regulation. It also protects cells from TNF-alpha-induced apoptosis. . FUNCTION: Phosphorylates Ins(1,3,4,5,6)P5 at position 2 to form Ins(1,2,3,4,5,6)P6 (InsP6 or phytate). . |
Accessions | ENST00000287996.8 ENST00000375522.2 X6R9A6 Q9H8X2 |